Lecture 21: Neoplasia III Flashcards
CRC staging
1 determinant for outcome
T: tumor depth
N: node involvement
M: metastasis
CRC prevention
5-10 yr progression from benign -> malignant polyp -> advanced CRC
- Red flag symptoms
- CRC screening
- Removal of adenoma precursors (size -> polyp danger)
CRC screening methods
- Colon-/sigmoidoscopy
- CT colonography
- Fecal Occult Blood Test (FOBT)
- Fecal Immunohistochemical Test (FIT)
- Fecal DNA test (Cologuard)
- Cell free DNA blood test (cfDNA)
2 progression paths from normal colon to CRC
- APC: Adenomatous Polyposis Coli gene
- KRAS-BRAF-MAPK path: serrated polyp neoplasia
APC gene
Cytoplasmic protein in colon mucosal crypt; sequesters beta-catenin for growth, adhesion
- Mx -> Wnt -> division w/o maturation
APC gene CRC progression
- APC Mx -> tubular adenoma dysplasia (Upreg. COX-2, EGFR, hypomethyl.)
- Advanced adenoma (KRAS oncogene, villous/tubulovillous polyp)
- Low to high grade dysplasia (cancer w/o invasion, often p53 Mx, nuclear atypia)
- CRC chr. changes (CIN -> aneuploid, del18q for DCC, SMAD2/4 suppressors)
Molecular mechanisms for colon neoplasia progression
- CIN, aneuploidy
Serrated path: - CpG island methylation (CIMP-H)
- MMR deficiency -> MSI
Serrated polyp neoplasia pathway
- KRAS or BRAF oncogene Mx -> precursor lesions -> senescence (serrated not dysplastic, hypermature)
- Hyperplastic polyps: 2 variations
- KRASmut GCHP
- BRAFmut MVHP - SSA or TSA pathways, depending on SSI
KRASmut GCHP
Goblet Cell Hyperplastic Polyp
- Minimal serration
- KRAS Mx
BRAFmut MVHP
MicroVesicular Hyperplastic Polyp
- Prominent serration
- BRAF Mx
Senescence
Adaptation to oncogene activation causing G1 arrest
e.g. BRAF -> upreg. of p16, p14 cell cycle inhibitors -> senescence
- Can be inactivated by CIMP
Classes of serrated polyps
- Self-limited:
- Hyperplastic GCHP, MVHP - Cancer precursor:
- Sessile Serrated Adenoma
- Traditional Serrated Adenoma
SSA carcinoma
Sessile Serrated Adenoma
- BRAFmut
- Diploid
- MMR deficit -> microsatellite instability (MSI)
- CIMP-H
- Well-differentiated serrated glands
- Peri/intratumoral lymphocytes
TSA carcinoma
Traditional Serrated Adenoma
- BRAF or KRASmut
- CIMP-H of suppressors
- MSS (microsatellite stable)
- Lymphatic invasion